Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.7300 (-3.99%) ($19.7000 - $20.7700) on Thu. Feb. 21, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.34% (three month average) | RSI | 33 | Latest Price | $19.7300(-3.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.67% in a week (0% probabilities). VXX(-12%) VIXM(-8%) XHB(-4%) TLT(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.67% (StdDev 5.34%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
Resistance Level | $20.59 | 5 Day Moving Average | $20.09(-1.79%) | 10 Day Moving Average | $19.99(-1.3%) | 20 Day Moving Average | $20.59(-4.18%) | To recent high | -37.9% | To recent low | 8.5% | Market Cap | $1.225b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |